Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-10-02
2007-10-02
Haddad, Maher M. (Department: 1644)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007920, C530S326000, C530S327000, C530S328000, C530S329000
Reexamination Certificate
active
10376121
ABSTRACT:
A number of octapeptides were generated from the sequences encoding the 60 kDa Ro/SSA peptide, the La/SSB autoantigen, the 70 kD nuclear ribonucleoprotein (nRNP), and the Sm B/B′ polypeptide, which represent linear epitopes for autoantibodies present in the sera of SLE and SS patients. These peptides are useful in solid phase assays for patients characterized by the presence of these autoantibodies, and can be used to categorize patients as to the likelihood of developing certain conditions associated with SLE. The peptides are also potentially useful in treatment of these patients using immobilized peptide to remove autoantibody and to block binding of the autoantibodies with patient molecules reactive with the autoantibodies.
REFERENCES:
patent: 4554101 (1985-11-01), Hopp
patent: 4784942 (1988-11-01), Harley
patent: 4865970 (1989-09-01), Brot et al.
patent: 5312752 (1994-05-01), Wotiz et al.
patent: 5354691 (1994-10-01), Van Eden et al.
patent: 0 313 156 (1989-04-01), None
patent: WO88/09932 (1988-12-01), None
patent: WO91/11718 (1991-08-01), None
patent: WO91/17171 (1991-11-01), None
patent: WO94/02445 (1994-02-01), None
patent: WO94/02509 (1994-02-01), None
The Merck Manual of Diagnosis and therapy, vol. 17, 1999.
James, J.A. and J.B. Hartley. ‘Sequential Epitopes of an Sm B/B' Protein.’ Arthritis and Rheumatism. 34(9): S133, 1991.
Alexander, et al., “Anti-Ro/SS-A antibodies in the pathophysiolgy of congenital geart block in neonatal lupus syndrome, an experimental model,” Arth. Rheum. 35: 176-189 (1992).
Alspaugh, et al., “Differentiation and characterization of autoantibodies and their antigens in Sjogren's syndrome,” Arthr. Rheum. 19: 216-222 (1976).
Bachmann, et al., “Characterization of the autoantigen La as a nucleic acid-dependent ATPase/dATPase with melting properties,” Cell 60: 85-93 (1990).
Banerjee, et al., “Complete nucleotide sequence of the mRNA coding for the N protein of vesicular stomatitis virus (New Jersey Serotype),” Virology 137:432-438 (1984).
Barakat, et al., “Recognition of synthetic peptides of Sm-D autoantigen bu lupus sera,” Clin. Exp. Immunol. 81: 256-262 (1990).
Barakat, et al., “IgG antibodies from patients with primary Sjogren's syndrome and systemic lupus erythematosus recognize different epitopes in 60-kD SSA/Ro protein,” Clin. Exp. Immunol. 89: 38-45 (1992).
Ben-Chetrit, et al., “Isolation and characterization of a cDNA encoding the 60-kD component of the human SS-A/Ro ribonucleoprotein autoantigen,” J. Clin. Inv. 83: 1284-1292 (1989).
Bernstein, et al., “Cellular protein and RNA antigens in autoimmune disease,” Mol. Biol. Med. 2: 105-120 (1984).
Blank, et al., “Induction of experimental anti-phospholipid syndrome associated with SLE following immunization with human monoclonal pathogenic anti-DNA idiotype,” J. Autoimmunity 5: 495-509 (1992).
Blank, et al., “Induction of SLE-like disease in naive mice with a monoclonal anti-DNA antibody derived from a patient with polymyositis carrying the 16/6 Id,” J. Autoimmunity 1: 683-691 (1988).
Blank, et al., “Induction of systemic lupus erythematosus in naive mice with T-cell lines specific for human anti-DNA antibody SA-1 (16/6 Id+),” Clin. Immunol. Immunopathol. 60: 471-483 (1991).
Blank, et al., “Sex hormone involvement in the induction of experimental systemic lupus erythematosus by a pathogenic anti-DNA idiotype in naive mice,” J. Rheumatol. 17: 311-317 (1990).
Blank, et al., “The effect of the immunomodulator agent AS101 on interleukin-2 production in synthetic lupus erythematosus (SLE) induced in mice by a pathogenic anti-DNA antibody,” Clin. Exp. Immunol. 79: 443-447 (1990).
Buyon, “Neonatal lupus syndromes,” Curr. Opin. in Rhuem. 6: 523-529 (1994).
Chambers, et al., “Genomic structure and amino acid sequence domains of the human La autoantigen,” J. Biol. Chem. 263: 18043-18051 (1988).
Chambers & Keene, “Isolation and analysis of cDNA clones expressing human lupus La antigen,” Proc. Natl. Acad. Sci. USA 82: 2115-2119 (1985).
Chan, et al., “Ribonucleoprotein SS-B/La belongs to a protein family with consensus sequences for RNA-binding,” Nucl. Acids Res. 17: 2233-2244 (1989).
Cohen, “The self, the world and autoimmunity,” Scientific American 258: 52-60 (1988).
Colman, “Effects of amino acid sequence changes on antibody-antigen interactions,” Res. Immunol. 145: 33-36 (1994).
Craft, et al., “Murine and drosophila B proteins of SM snRNPS,” Mol. Biol. Rep. 15: 159 (1991).
Depolo, et al., “Continuing coevolution of virus and defective interfering particles and of viral genome sequences during undiluted passages: virus mutants exhibiting nearly complete resistance to formerly dominant defective interfering particles,” J.Virology 61: 454-464 (1987).
Deutscher, et al., “Molecular analysis of the 60-kDa human Ro ribonucleoprotein,” Proc. Natl. Acad. Sci. USA 85: 9479-9483 (1988).
Dickey, “Human autoantibody producing grafts in SCID mice,” presented to the Oklahoma Lupus Association, Sep. 1989 (abstract).
Dyrberg, et al., “Peptides as probes to study molecular mimicry and virus-induced autoimmunity,” Current Topics in Microbiol. 130: 25-37 (1986).
Elkon, et al., “Epitope mapping of recombinant HeLa SmB and B1peptides obtained by the polymerase chain reaction,” J. Immun. 145: 636-643 (1990).
Esquivel, et al., “Induction of autoimmunity in good and poor responder mice with mouse thyrobglobulin and lipopolysaccharide,” J. Exp. Med. 145: 1250-1263 (1977).
Ferris & Donaldson, “An enzyme-linked immunosorbent assay for the detection of vesicular stomatitis virus antigen,” Vet. Biol. 18(3-4): 243-258 (1988).
Fisher, “Temporal shifts from Sm to ribonucleoprotein reactivity in systemic lupus erythematosus,” Arthritis Rheum. 28: 1348 (1985).
Fricke, et al., “Induction of experimental systemic lupus erythematosus in mice by immunization with monoclonal anti-La autoantibody,” Intern. Immunol. 2: 225-230 (1990).
Fritz, et al., “Small nuclear U-ribonucleoproteins inXenopus laevisdevelopment,” J. Mol. Biol. 178: 273-285 (1984).
Gaither, et al., “Affinity purification and immunoassay of anti-Ro/SSA,” Protides Biol. Fluids 33: 413-416 (1985).
Gallione, et al., “Nucleotide sequences of the mRNA's encoding the vesicular stomatitis virus N and NS proteins,” Virology 39: 529-535 (1981).
Geysen, et al., “Strategies for epitope analysis using peptide synthesis,” J. Immun. Methods 102: 259-271 (1987).
Geysen, et al., “Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid,” Proc. Natl. Acad. Sci. USA 81: 3998-4002 (1984).
Gottlieb & Steitz, “The RNA binding protein La influences both the accuracy and the efficiency of RNA polymerase III transcription in vitro,” EMBO J. 8: 841 (1989).
Guldner, et al., “Epitope mapping with a recombinant human 68-kDa (U1) ribonucleoprotein antigen reveals heterogenous autoantibody profiles in human autoimmune sera,” J. Immunol. 141(2): 469-475 (1988).
Habets, et al., “Characterization of the SS-B (La) antigen in adenovirus infected and uninfected HeLa cells,” EMBO J. 2: 1625 (1983).
Harley, et al., “Anti-Ro (SS-A) and Anti-La (SS-B) in patients with Sjogren's Syndrome,” Arthritis Rheum. 29: 196-206 (1986).
Harley & Gaither, Autoantibodies. In Rheumatic Disease Clinics of North American: Systemic Lupus Erythematosus, 14: 43-56 (1988).
Harley, et al., Arthritis Rheum. 28: 1321-1325 (1985).
Herbert, et al., Dictionary of Immunology, 3rdEd., Blackwell Scientific Publications: Oxford, UK, p. 14 (1995).
Hinterberger, et al., “Isolation of small nuclear ribonucleoproteins containing U1, U2
Harley John B.
James Judith A.
Fulbright & Jaworski LLP
Haddad Maher M.
Oklahoma Medical Research Foundation
Rooney Nora M.
LandOfFree
Methods and reagents for diagnosis of autoantibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and reagents for diagnosis of autoantibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and reagents for diagnosis of autoantibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3901391